Western Blotting Global Market Report 2026

Western blotting is a laboratory technique used to detect and analyze specific proteins within a sample. The process involves separating proteins via gel electrophoresis, transferring them onto a membrane, and using antibodies to identify the target protein. This technique is essential for examining protein expression, molecular weight, and post-translational modifications.

The western blotting market primarily comprises instruments and consumables. Western blotting instruments are specialized laboratory devices designed to carry out the Western blot technique for detecting and analyzing specific proteins in samples. Applications of this technique span scientific research, medical diagnostics, agriculture, food and beverage industries, among others. The end-users include academic and research institutions, pharmaceutical and biotechnology companies, diagnostic centers, and additional sectors.

Tariffs are impacting the western blotting market by increasing costs of imported laboratory instruments, imaging systems, antibodies, reagents, membranes, and precision consumables. Academic research institutes and pharmaceutical laboratories in North America and Europe are most affected due to reliance on imported scientific equipment, while Asia-Pacific faces cost pressure on reagent manufacturing. These tariffs are increasing operational expenses and delaying laboratory upgrades. However, they are also encouraging domestic reagent production, regional instrument manufacturing, and innovation in cost-efficient and automated western blotting platforms.

The western blotting market research report is one of a series of new reports from The Business Research Company that provides western blotting market statistics, including western blotting industry global market size, regional shares, competitors with a western blotting market share, detailed western blotting market segments, market trends and opportunities, and any further data you may need to thrive in the western blotting industry. This western blotting market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The western blotting market size has grown strongly in recent years. It will grow from $1.39 billion in 2025 to $1.52 billion in 2026 at a compound annual growth rate (CAGR) of 9.2%. The growth in the historic period can be attributed to expansion of life science research activities, growing use of protein analysis in diagnostics, increased academic research funding, widespread adoption of antibody-based assays, rising pharmaceutical research investments.

The western blotting market size is expected to see strong growth in the next few years. It will grow to $2.14 billion in 2030 at a compound annual growth rate (CAGR) of 9.0%. The growth in the forecast period can be attributed to increasing demand for biomarker-based diagnostics, expansion of proteomics research, growing automation in laboratory workflows, rising focus on high-throughput protein analysis, increasing use of western blotting in clinical research. Major trends in the forecast period include increasing adoption of automated western blot systems, rising demand for high-sensitivity protein detection, growing use of ready-to-use reagent kits, expansion of digital imaging and analysis tools, enhanced focus on reproducibility and standardization.

The growing prevalence of human immunodeficiency virus (HIV) is anticipated to drive the expansion of the western blotting market. HIV is a virus that compromises the immune system, reducing the body's ability to combat infections and illnesses. The increasing incidence of HIV is primarily linked to insufficient awareness and education regarding preventive measures, which raises the risk of transmission. Western blotting is a key diagnostic method used for confirming HIV infections, playing a critical role in early detection and timely treatment, which are vital for effective disease management. For example, in October 2024, Gov.UK, a UK government agency, reported 6,402 HIV diagnoses in the UK (excluding Northern Ireland) in 2023 an increase of 46% from 4,379 cases in 2022. Consequently, the rising number of HIV cases is contributing to the growth of the western blotting market.

Leading companies in the western blotting market are prioritizing the development of cutting-edge imaging systems, such as complementary metal-oxide-semiconductor (CMOS) digital imaging and stain-free imaging technologies to improve image clarity, precision in protein quantification, and overall research throughput. CMOS digital imaging captures gel and blot images with high sensitivity using advanced sensors, while stain-free imaging technology allows total protein normalization without additional steps such as probing or stripping, streamlining the western blot process. For instance, in July 2024, Bio-Rad, a US-based biotech firm, introduced the ChemiDoc Go Imaging System. This compact imaging system integrates CMOS digital and stain-free imaging technologies, enhancing sensitivity, accuracy, and efficiency in western blotting and gel imaging. It is particularly suited for protein quantification and quality control in life science research.

In September 2024, Leinco Technologies Inc., a US-based biotechnology firm, acquired QED Biosciences for an undisclosed sum. This acquisition is intended to expand Leinco's catalog of high-quality antibodies, reagents, and development services, thereby strengthening its standing in the global antibody market. It also enhances the company's capabilities in supporting research and in vitro diagnostics (IVD), encouraging innovation and delivering greater value to scientists and healthcare professionals. QED Biosciences, also based in the US, specializes in antibodies and recombinant proteins commonly used in western blotting.

Major companies operating in the western blotting market are Hoffmann-La Roche Ltd., Thermo Fisher Scientific, Danaher Corporation, Merck KGaA, GE Healthcare, EMD Millipore, PerkinElmer Inc., Bio-Rad Laboratories, GeneTex Inc., GenScript Biotech, Abcam plc, Promega Corporation, Takara Bio Inc., Cell Signaling Technology, Proteintech Group Inc., Cygnus Technologies, Santa Cruz Biotechnology, Abnova Corporation, Azure Biosystems Inc., Leinco Technologies Inc., LI-COR Biosciences GmbH, Novus Biologicals LLC

North America was the largest region in the western blotting market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the western blotting market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the western blotting market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The western blotting market consists of revenues earned by entities by providing services such as sample preparation, custom assay development, equipment maintenance, antibody probing, and antibody probing. The market value includes the value of related goods sold by the service provider or included within the service offering. The western blotting market also includes sales of transfer membranes, protein markers, chemiluminescent substrates, power supplies, and secondary antibodies. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Western Blotting Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses western blotting market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on end user analysis.
• Benchmark performance against key competitors based on market share, innovation, and brand strength.
• Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
• Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for western blotting ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The western blotting market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
• The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
• The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
• The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
• The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
• The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

• Markets Covered:1) By Product: Instruments; Consumables
• 2) By Application: Scientific Research; Medical Diagnostics; Agricultural Application; Food And Beverages; Other Applications
• 3) By End-Users: Academic And Research Institutes; Pharmaceutical And Biotechnology Companies; Diagnostic Centers; Other End-Users
• Subsegments:
• 1) By Instruments: Gel Electrophoresis Instruments; Blotting Systems; Imagers
• 2) By Consumables: Reagents; Kits
• Companies Mentioned: Hoffmann-La Roche Ltd.; Thermo Fisher Scientific; Danaher Corporation; Merck KGaA; GE Healthcare; EMD Millipore; PerkinElmer Inc.; Bio-Rad Laboratories; GeneTex Inc.; GenScript Biotech; Abcam plc; Promega Corporation; Takara Bio Inc.; Cell Signaling Technology; Proteintech Group Inc.; Cygnus Technologies; Santa Cruz Biotechnology; Abnova Corporation; Azure Biosystems Inc.; Leinco Technologies Inc.; LI-COR Biosciences GmbH; Novus Biologicals LLC
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: Word, PDF or Interactive Report
• + Excel Dashboard
• Added Benefits
• Bi-Annual Data Update
• Customisation
• Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.